{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:37:59Z","timestamp":1788212279558,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.urology.2015.04.047","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T20:19:36Z","timestamp":1437250776000},"page":"291-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Self-report and Clinical Response to Peyronie's Disease Treatment: Peyronie's Disease Questionnaire Results From 2 Large Double-Blind, Randomized, Placebo-Controlled Phase 3 Studies"],"prefix":"10.1016","volume":"86","author":[{"given":"Wayne J.G.","family":"Hellstrom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin S.","family":"Coyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Tursi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2015.04.047_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000096927","article-title":"Peyronie's disease: lights and shadows","volume":"78","author":"Sasso","year":"2007","journal-title":"Urologia Internationalis"},{"key":"10.1016\/j.urology.2015.04.047_bib2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1517\/14656566.2011.544252","article-title":"Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options","volume":"12","author":"Gur","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.urology.2015.04.047_bib3","first-page":"1527","article-title":"Peyronie's disease (CME)","volume":"4","author":"Bella","year":"2007","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.urology.2015.04.047_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ucl.2011.03.001","article-title":"Peyronie disease: plication or grafting","volume":"38","author":"Langston","year":"2011","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urology.2015.04.047_bib5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11934-011-0212-2","article-title":"Treatment of Peyronie's disease: 2012 update","volume":"12","author":"Serefoglu","year":"2011","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.urology.2015.04.047_bib6","first-page":"2359","article-title":"The management of Peyronie's disease: evidence-based 2010 guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.urology.2015.04.047_bib7","series-title":"Xiaflex\u00ae (Collagenase Clostridium histolyticum) [Prescribing Information]","year":"2014"},{"issue":"suppl 5","key":"10.1016\/j.urology.2015.04.047_bib8","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1038\/sj.ijir.3901083","article-title":"Establishing a standardized evaluation of the man with Peyronie's disease","volume":"15","author":"Levine","year":"2003","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2015.04.047_bib9","first-page":"414","article-title":"Standards for clinical trials in male sexual dysfunctions","volume":"7","author":"Porst","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.urology.2015.04.047_bib10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1464-410X.2005.05391.x","article-title":"Peyronie's disease: the epidemiology, aetiology and clinical evaluation of deformity","volume":"95","author":"Smith","year":"2005","journal-title":"BJU Int"},{"issue":"suppl 3","key":"10.1016\/j.urology.2015.04.047_bib11","first-page":"S68","article-title":"Peyronie's Disease Index (PDI) a standardized patient questionnaire [abstract]","volume":"14","author":"Shabsigh","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2015.04.047_bib12","first-page":"1977","article-title":"Impact of Peyronie's disease on sexual and psychosocial functioning: qualitative findings in patients and controls","volume":"5","author":"Rosen","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.urology.2015.04.047_bib13","first-page":"627","article-title":"Bother and distress associated with Peyronie's disease: validation of the Peyronie's Disease Questionnaire (PDQ)","volume":"190","author":"Hellstrom","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2015.04.047_bib14","first-page":"199","article-title":"Clinical efficacy, safety and tolerability of collagenase Clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2015.04.047_bib15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.urology.2015.04.047_bib16","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.urology.2015.04.047_bib17","first-page":"2115","article-title":"An analysis of the natural history of Peyronie's disease","volume":"175","author":"Mulhall","year":"2006","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2015.04.047_bib18","first-page":"2822","article-title":"Baseline characteristics from an ongoing phase 3 study of collagenase Clostridium histolyticum in patients with Peyronie's Disease","volume":"10","author":"Gelbard","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.urology.2015.04.047_bib19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.eururo.2005.10.026","article-title":"Prevalence of Peyronie's disease among patients with erectile dysfunction","volume":"49","author":"El-Sakka","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2015.04.047_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ijir.3901518","article-title":"The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction","volume":"19","author":"Arafa","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2015.04.047_bib21","first-page":"1026","article-title":"Peyronie's disease in diabetic patients being screened for erectile dysfunction","volume":"174","author":"El-Sakka","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2015.04.047_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/bju.13096","article-title":"Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroups: results from two large, double-blind, randomized, placebo-controlled, phase 3 studies","author":"Lipshultz","year":"2015","journal-title":"BJU Int"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429515005440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429515005440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T20:51:01Z","timestamp":1537476661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429515005440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0090429515005440"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2015.04.047","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-report and Clinical Response to Peyronie's Disease Treatment: Peyronie's Disease Questionnaire Results From 2 Large Double-Blind, Randomized, Placebo-Controlled Phase 3 Studies","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2015.04.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}